Efficacy and safety of TROP2 antibody-drug conjugate-containing regimen in the patients with HER2 negative metastatic breast cancer and advanced non-small-cell lung cancer

JOURNAL OF CHEMOTHERAPY · Published 2026-07-29 · DOI 10.1080/1120009x.2026.2708448

Authors (7)

Yangqingqing Zhou, Wunan Huang, Hui Wang, Xinyue Hang, Haitao Jin, Ruiyuan He, Chaosheng Gan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhou, Y., Huang, W., Wang, H., et al. (2026). Efficacy and safety of TROP2 antibody-drug conjugate-containing regimen in the patients with HER2 negative metastatic breast cancer and advanced non-small-cell lung cancer. JOURNAL OF CHEMOTHERAPY. https://doi.org/10.1080/1120009x.2026.2708448

Related articles